🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

JAMA Guide to Statistics and Methods: Factorial clinical trial designs allow for the simultaneous evaluation of multiple treatments and their interactions. ja.ma/41iGzZj

Excited that at #ESCMIDGlobal 2025, SNAP trial results for PSSA and MSSA silo backbone domains will be presented. What's more it's a new format 2 hour session! 3 trials (SNAPx2, CLOCEBA), with expert led & audience discussion. Sat April 12 16:15 - 18:15 Hall 13 Drinks after

3GC resistant meningococcus pmc.ncbi.nlm.nih.gov/articles/PMC11…

As the day sets on International Women's Day, I am reflecting on how lucky we all are that this group of women is helping the world to develop new products for antibiotic-resistant bacterial infections. CARB-X

MORU-OUCRU Discovery Research Academy (MODRA) applications are now open! An 18-mth programme for early to mid-career postdocs, with expert-led training, mentorship & funding to advance your career in global health & infectious diseases! Find out more: oucru.org/modra/

Read the latest article from Professor Dame Sally Davies (UK Special Envoy on AMR) and Nikolaj Gilbert (President & CEO of PATH). There is a looming antibiotic emergency, and the time for global action is now: telegraph.co.uk/global-health/…

Excited to announce that we randomised our first patient into the #ROADMAPtrial today! First of thousands, answering important questions in prosthetic joint infection. See roadmaptrial.com for more deets. #IDXposts #PJI

Just out.! Led by Mariana Barosa we revisit target trial emulation. We show, under a variety of scenarios, real world evidence is actually MORE EXPENSIVE to generate than randomized evidence See tables & figures in thread VKPrasadLab

New review article on management of S. aureus bacteraemia: jamanetwork.com/journals/jama/… JAMA Check out the gorgeous Figure which brings together elements of pathogenesis and management: (thread)

Brad Spellberg Beg to differ! The world is bigger than the US, and outside Nth America most ID specialists prefer(ed) ASPs. Yes guidelines and expert opinion are part of the reason. BUT lack of RCTs was a crucial part.

Brad Spellberg We should not change or base our practice on observational studies. They are often wrong. In this case they were not, but the only was of knowing that for sure is to remove bias by doing big RCTs

ARLG Network member David Paterson gave a keynote at #ESCMIDGlobal, Asia: An AMR hot zone. He discussed the antimicrobial resistance crisis in Asia and strategies to address this global health concern. Learn how the #ARLGnetwork is working to fight #AMR: arlg.org

Great presentation by Helmi Sulaiman at ESCMID GLOBAL on Acinetobacter

In combination with other antibiotics, IV fosfomycin is a regimen in all domains of the TREAT-GNB platform

Vietnam’s historic Reunification parade 🇻🇳 #50th #30-4

POPPK: FROM FUNDAMENTALS TO CLINICAL PRACTICE. Are you new to PK or looking to refresh your understanding of the basics? This beginner-friendly 3-day workshop is designed to take you from core PK concepts to understanding how popPK are applied in research and clinical practice.

Jom join Steven Tong and Patrick Harris as they discuss the challenges of post-trial access to antibiotics — a frustrating reality for many LMICs, including Malaysia! #AccessToMedicines Global Antibiotic R&D Partnership (GARDP) Dr Syamhanin Adnan AdamJ Rahela ambaras khan MyICID Steven Lim revive.gardp.org/post-licensing…

Carbapenem-resistant Acinetobacter baumannii (CRAB) accounted for more than 1/3 of all A baumannii infections from 2018 through 2022 and is increasingly more common, according to a new study cidrap.umn.edu/antimicrobial-… via CIDRAP #AMR

🚨 This is Big! New GARDP research shows that people with multidrug-resistant infections in LMICs are not receiving the appropriate antibiotics because of large gaps in access. Improving access and developing new antibiotics must be a priority, 📖 Read the study 👇

Another brilliant episode on #communicable hosted by Dr Erin McCreary & Dr Angela Huttner from practice changing SNAP Trial with Steven Tong & Joshua Davis on the results, which was recently presented at #ESCMIDGlobal2025. ESCMID CMI Communications